BTG plc (LON:BTG – Get Rating)’s stock price passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 840 ($10.40) and traded as high as GBX 840 ($10.40). BTG shares last traded at GBX 840 ($10.40), with a volume of 271,742 shares traded.
BTG Stock Performance
The stock has a market capitalization of £3.26 billion and a price-to-earnings ratio of 29.47. The business has a 50 day simple moving average of GBX 840 and a 200-day simple moving average of GBX 840.
BTG Company Profile
BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications.
Further Reading
- Is The Bottom In For Cyber-Security Stocks?
- Union Pacific, Norfolk Southern Pull into Buying Zone
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
Receive News & Ratings for BTG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG and related companies with MarketBeat.com's FREE daily email newsletter.
